WASHINGTON - For months, Reta Mays' treachery slipped through the cracks at the VA hospital center in West Virginia, where ...

Insulet's impressive growth with its Omnipod system, robust 2024 results, and surging valuation make it attractive. See more ...

Patients visiting clinics across multiple hospitals are facing severe difficulties due to an insufficient supply of insulin, chairman of the Doctors’ Trade Union Alliance for Medical and Civil Rights, ...

The Helmsley Charitable Trust’s T1D Exercise Initiative ( T1-DEXI) datasets provide baseline information on the glycemic ...

The company produces and sells Omnipod, an automated insulin delivery device, which works without the need for external ...

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

Merilog is expected to be available in July 2025, and Sanofi will provide Merilog to patients for $35 or less for a 30-day ...

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

Researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch applied to the skin. One day, researchers want to use switches of this kind to ...